Full Text View
Tabular View
No Study Results Posted
Related Studies
Left Ventricular Capture Management (LVCM) Software Download Clinical Trial
This study has been completed.
Study NCT00268281   Information provided by Medtronic Cardiac Rhythm Disease Management
First Received: December 21, 2005   Last Updated: October 11, 2006   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

December 21, 2005
October 11, 2006
December 2004
To evaluate the accuracy of left ventricular capture management (LVCM)
Same as current
Complete list of historical versions of study NCT00268281 on ClinicalTrials.gov Archive Site
  • To compare left ventricular capture management (LVCM) measurements to a similar measurement taken automatically when subjects are completing normal daily activities
  • To evaluate subject rhythm and rate immediately following an LVCM measurements
  • To characterize all adverse events
Same as current
 
Left Ventricular Capture Management (LVCM) Software Download Clinical Trial
Left Ventricular Capture Management (LVCM) Software Download Clinical Trial

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed.

Left Ventricular Capture Management (LVCM) refers to the overall method for determining left ventricular thresholds (level of energy needed to effectively pace the tissue in the lower left chamber of the heart) by measuring, analyzing, and adjusting energy delivered from the CRT device to the pacing lead.

The purpose of the Left Ventricular Capture Management Software Download Clinical Trial was to evaluate the accuracy of the Left Ventricular Capture Management (LVCM) feature to support LVCM feature approval in future cardiac resynchronization therapy with defibrillation (CRT-D) devices

 
 
Interventional
Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Heart Failure
Device: Left Ventricular Capture Management Software
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
107
July 2005
 

Inclusion Criteria:

  • Subjects who successfully underwent implantation of an InSync II Marquis system

Exclusion Criteria:

  • Subjects who are post-heart transplant
  • Subjects enrolled in a concurrent study that may confound the results of this study
Both
18 Years and older
No
 
United States
 
 
NCT00268281
 
 
Medtronic Cardiac Rhythm Disease Management
 
 
Medtronic Cardiac Rhythm Disease Management
October 2006

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.